HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $156,000 | +178.6% | 3,553 | +153.4% | 0.01% | +200.0% |
| Q4 2021 | $56,000 | +21.7% | 1,402 | +24.4% | 0.00% | +100.0% |
| Q3 2021 | $46,000 | -42.5% | 1,127 | -36.1% | 0.00% | -66.7% |
| Q2 2021 | $80,000 | -12.1% | 1,765 | -17.2% | 0.00% | -25.0% |
| Q4 2020 | $91,000 | -33.1% | 2,131 | -58.1% | 0.00% | -73.3% |
| Q2 2020 | $136,000 | +518.2% | 5,083 | +310.6% | 0.02% | +50.0% |
| Q1 2020 | $22,000 | -60.7% | 1,238 | -60.8% | 0.01% | -23.1% |
| Q4 2019 | $56,000 | +5500.0% | 3,161 | +5978.8% | 0.01% | – |
| Q3 2018 | $1,000 | 0.0% | 52 | +67.7% | 0.00% | -100.0% |
| Q1 2018 | $1,000 | 0.0% | 31 | -78.6% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | -98.8% | 145 | -97.9% | 0.00% | -97.8% |
| Q3 2016 | $82,000 | – | 6,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |